CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2024.1422681
Abstract: Introduction With the advent of anti-β-amyloid therapies, clinical distinction between Aβ + and Aβ− in cognitive impairment is becoming increasingly important for stratifying referral and better utilization of biomarker assays. Methods Cognitive profile, rate of decline, neuropsychiatric… read more here.
Keywords: amyloid positivity; positivity prediction; clinical tool; positivity ... See more keywords